Page last updated: 2024-11-09

5-iodouridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-iodouridine: RN given refers to unlabeled cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1268108
CHEMBL ID3249838
SCHEMBL ID97335
MeSH IDM0109914

Synonyms (30)

Synonym
5-iodouridine
uridine, 5-iodo-
1024-99-3
nsc-523375
5-iodouridine, 95%
A800578
1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione;nsc 523375; ac1l5tpi
1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1h,3h)-dione
unii-yzk4kvc76p
nsc 523375
yzk4kvc76p ,
einecs 213-833-1
AKOS015896912
2,4-dihydroxy-5-iodo-1-beta-d-ribofuranosylpyrimidine
CHEMBL3249838
1-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodopyrimidine-2,4(1h,3h)-dione
SCHEMBL97335
AC-32308
c9h11in2o6
mfcd00006532
5-iodouridine, >=97.0% (hplc)
DS-10692
1-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1h,3h)-dione
1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione
AMY40627
EN300-221745
1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione
F12678
Z2197277787
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1135723Growth inhibition of human MGL8 cells at 5 uM after 48 hrs1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Synthesis of branched-chain apiosylpyrimidines and their inhibition of lymphocyte proliferation.
AID1135725Growth inhibition of human MGL8 cells at 500 uM after 48 hrs relative to control1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Synthesis of branched-chain apiosylpyrimidines and their inhibition of lymphocyte proliferation.
AID1135724Growth inhibition of human MGL8 cells at 50 uM after 48 hrs relative to control1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Synthesis of branched-chain apiosylpyrimidines and their inhibition of lymphocyte proliferation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (28.57)18.7374
1990's3 (21.43)18.2507
2000's3 (21.43)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.67 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]